Press Releases from DelveInsight (457 total)
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes,…
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic…
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer…
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a…
Pemphigus Vulgaris Clinical Trials 2025: Emerging Therapies, Key Players, and Tr …
DelveInsight's "Pemphigus Vulgaris - Pipeline Insight, 2025" provides a comprehensive overview of the evolving treatment landscape for pemphigus vulgaris, a rare, chronic, and potentially life-threatening…
Peripheral Arterial Clinical Trial Analysis 2025: 22+ Emerging Therapies, Novel …
DelveInsight's "Peripheral Arterial Disease - Pipeline Insight, 2025" explores over 22+ therapies in development for peripheral arterial disease (PAD), a chronic and progressive condition caused…
Ovarian Cancer Clinical Trial Analysis 2025: 200+ Pipeline Drugs, PARP Inhibitor …
DelveInsight's "Ovarian Cancer - Pipeline Insight, 2025" reviews over 200+ therapies in development for ovarian cancer, one of the most challenging gynecologic malignancies with high…
HER2-Positive Breast Cancer Pipeline Insight 2025: 55+ Pipeline Drugs, Targeted …
DelveInsight's "HER2-Positive Breast Cancer - Pipeline Insight, 2025" highlights over 55+ therapies in development for HER2-positive breast cancer, one of the most aggressive breast cancer…
Focal Segmental Glomerulosclerosis Pipeline Insight 2025: 18+ Emerging Therapies …
DelveInsight's "Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025" reviews more than 18+ therapies in development for focal segmental glomerulosclerosis (FSGS), a rare and severe form…
Non-Muscle Invasive Bladder Cancer Pipeline Insight 2025: 22+ Emerging Therapies …
DelveInsight's "Non-Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" highlights more than 22+ therapies in development for non-muscle invasive bladder cancer (NMIBC). In this prevalent…
Leishmaniasis Pipeline Insight 2025: Emerging Drugs, Novel Antiparasitic Approac …
DelveInsight's "Leishmaniasis - Pipeline Insight, 2025" highlights over 3+ drugs in development for leishmaniasis, a neglected tropical disease caused by Leishmania parasites and transmitted through…
Liposarcoma Pipeline Insight 2025: 15+ Pipeline Drugs, Targeted Therapies, and I …
DelveInsight's "Liposarcoma - Pipeline Insight, 2025" explores over 15+ therapies in development for liposarcoma, a rare and heterogeneous soft tissue sarcoma subtype. Despite surgery and…
Type 1 Diabetes Pipeline Insight 2025: 100+ Pipeline Drugs, Cell Therapies, and …
DelveInsight's "Type 1 Diabetes - Pipeline Insight, 2025" explores the fast-evolving pipeline of more than 100+ therapies in development for type 1 diabetes (T1D), an…
Atrial Fibrillation Pipeline Insight 2025: 15+ Pipeline Drugs, Gene Therapies, a …
DelveInsight's "Atrial Fibrillation - Pipeline Insight, 2025" examines more than 15+ therapies in development for atrial fibrillation (AF), the most common sustained cardiac arrhythmia associated…
TIL Therapy Pipeline Insight 2025: Harnessing Tumor-Infiltrating Lymphocytes to …
DelveInsight's "TIL Therapy - Pipeline Insight, 2025" provides an in-depth look at the rapidly expanding field of tumor-infiltrating lymphocyte (TIL) therapy, an adoptive cell therapy…
Norovirus Infection Pipeline Insight 2025: Advancing Antivirals and Vaccines to …
DelveInsight's "Norovirus Infection - Pipeline Insight, 2025" provides a comprehensive overview of the emerging therapies targeting norovirus, a highly contagious pathogen responsible for acute gastroenteritis…
Klebsiella Infections Pipeline Insight 2025: Innovative Antibiotics and Novel Th …
DelveInsight's "Klebsiella Infections - Pipeline Insight, 2025" explores the evolving landscape of therapies aimed at tackling Klebsiella pneumoniae and related species, which are major culprits…
Vancomycin Resistant Enterococcal Infections Pipeline Insight 2025: Novel Antibi …
DelveInsight's "Vancomycin Resistant Enterococcal (VRE) Infections - Pipeline Insight, 2025" highlights the evolving treatment landscape for one of the most pressing antimicrobial resistance (AMR) threats.…
Type 2 Diabetes Pipeline Insight 2025: Next-Gen Incretins, Gene Therapies, and M …
DelveInsight's "Type 2 Diabetes - Pipeline Insight, 2025" explores the evolving pipeline for type 2 diabetes (T2D), a chronic disorder marked by insulin resistance and…
Wet Age-Related Macular Degeneration Pipeline Insight 2025: Over 60+ Companies A …
DelveInsight's "Wet-AMD - Pipeline Insight, 2025" maps a fast-moving landscape for neovascular (wet) age-related macular degeneration, a leading cause of vision loss driven by choroidal…
Pulmonary Embolism Pipeline Insight 2025: Novel Anticoagulants, Thrombolytics, a …
DelveInsight's "Pulmonary Embolism - Pipeline Insight, 2025" explores the advancing treatment landscape for pulmonary embolism, a life-threatening condition resulting from obstruction of the pulmonary arteries,…
Immune Thrombocytopenia Clinical Trials 2025: Advancing TPO-R Agonists, FcRn Blo …
DelveInsight's "Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025" highlights the rapidly evolving therapeutic landscape for ITP, an autoimmune bleeding disorder characterized by accelerated platelet destruction…
Graft Preparation System Market to Register a CAGR of 4.17% by 2032, Driven by R …
The graft preparation system market is anticipated to grow steadily, fueled by the increasing prevalence of orthopedic disorders, sports injuries, and cardiovascular diseases that demand…
High-Throughput Screening Market to Register a CAGR of 10.61% by 2032, Driven by …
The high-throughput screening (HTS) market is set for significant growth, driven by the increasing demand for rapid drug discovery, rising investment in pharmaceutical research, and…
Healthcare Asset Management Market to Register a CAGR of 19.27% by 2032, Driven …
The healthcare asset management market is expected to experience significant growth, driven by rising investments in healthcare infrastructure, the increasing complexity of hospital equipment management,…
In Situ Hybridization Market to Register a CAGR of 7.12% by 2032, Driven by Risi …
The in situ hybridization (ISH) market is poised for substantial growth, fueled by the increasing demand for precision diagnostics, rising prevalence of cancer and genetic…
Transradial Access Products Market to Register a CAGR of 7.20% by 2032, Driven b …
The transradial access products market is expected to experience steady growth, fueled by the increasing adoption of transradial access in coronary angiography and percutaneous coronary…
Spinal Fusion Devices Market to Register a CAGR of 5.31% by 2032, Driven by Risi …
The spinal fusion devices market is expected to witness robust growth, fueled by the increasing prevalence of degenerative spinal disorders, trauma cases, and the growing…
Spinal Cord Stimulators Market to Register a CAGR of 9.83% by 2032, Driven by Ri …
The spinal cord stimulators market is set for substantial growth, propelled by the increasing prevalence of chronic pain conditions such as failed back surgery syndrome,…
Nuclear Imaging Equipment Market to Register a CAGR of 4.96% by 2032, Driven by …
The nuclear imaging equipment market is poised for substantial growth, fueled by the increasing prevalence of cancer and cardiovascular diseases, the growing demand for precision…
Surgical Energy Generators Market to Register a CAGR of 3.37% by 2032, Driven by …
The surgical energy generators market is set to witness steady growth, driven by the rising adoption of minimally invasive and laparoscopic procedures, increasing demand for…
Fuchs Dystrophy Pipeline Insight 2025: Emerging Cell and Gene Therapies Reshape …
DelveInsight's "Fuchs Dystrophy - Pipeline Insight, 2025" explores the dynamic pipeline for Fuchs Endothelial Corneal Dystrophy (FECD), a progressive eye disease characterized by corneal endothelial…
Polycystic 0vary Syndrome (PCOS) Pipeline Insight 2025: Innovative Hormonal and …
DelveInsight's "Polycystic 0vary Syndrome - Pipeline Insight, 2025" provides a thorough analysis of emerging therapeutic strategies for PCOS, a common endocrine disorder affecting reproductive-age…
Influenza A Virus H5N1 Subtype Pipeline Insight 2025: Next-Generation Vaccines a …
DelveInsight's "Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025" presents a detailed overview of the therapeutic landscape for H5N1, a highly pathogenic avian influenza…
Spasmodic Torticollis Pipeline Insight 2025: Novel Neurotoxins and Neuromodulati …
DelveInsight's "Spasmodic Torticollis - Pipeline Insight, 2025" provides a comprehensive analysis of the evolving treatment landscape for Spasmodic Torticollis (cervical dystonia), a chronic neurological disorder…
Achromatopsia Pipeline Insight 2025: Gene Therapy Leads the Charge in Restoring …
DelveInsight's "Achromatopsia - Pipeline Insight, 2025" offers an in-depth evaluation of the emerging therapeutic landscape for Achromatopsia (ACHM), a rare inherited retinal disorder caused by…
Chest Drainage Catheters Market to Grow at a CAGR of 4.78% by 2032, Driven by Ri …
The chest drainage catheters market is projected to grow steadily through 2032, supported by an increase in thoracic surgeries, rising incidence of pleural effusion, pneumothorax,…
Retinal Detachment Market to Witness Steady Growth by 2032, Driven by Rising Inc …
The retinal detachment market is projected to grow steadily through 2032, fueled by the rising incidence of retinal disorders linked to aging populations, diabetes, and…
Amniotic Membrane Market to Grow at a CAGR of 7.33% Through 2032, Driven by Risi …
The amniotic membrane market is projected to grow significantly through 2032, supported by its expanding clinical applications in ophthalmology, wound care, and regenerative medicine. Increasing…
Dysmenorrhea Treatment Market to Expand Strongly Through 2032, Driven by Rising …
The dysmenorrhea treatment market is expected to witness significant growth through 2032, driven by the rising prevalence of menstrual disorders among women of reproductive age…
Respiratory Inhalers Market to Grow at a CAGR of 4.65% by 2032, Driven by Rising …
The respiratory inhalers market is expected to witness steady growth through 2032, driven by the rising prevalence of asthma, chronic obstructive pulmonary disease (COPD), and…
Corneal Endothelial Dystrophy Pipeline Insight 2025: Cell-Based and Gene Therapi …
DelveInsight's "Corneal Endothelial Dystrophy - Pipeline Insight, 2025" provides a comprehensive exploration of the evolving therapeutic landscape for corneal endothelial dystrophies (CED), including Fuchs endothelial…
Hepatitis C Virus Infection Pipeline Insight 2025: Next-Generation Direct-Acting …
DelveInsight's "Hepatitis C Virus Infection - Pipeline Insight, 2025" provides a comprehensive overview of the evolving therapeutic landscape for HCV, a global health burden affecting…
Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight 2025: REZDIFFRA EU Approva …
On 19th August 2025, REZDIFFRA became the first and only therapy approved for Non-Alcoholic Steatohepatitis (NASH) in the EU, following a positive recommendation from the…
Propionic Acidemia Pipeline Insight 2025: Emerging Gene and Enzyme Therapies Aim …
DelveInsight's "Propionic Acidemia - Pipeline Insight, 2025" provides an in-depth analysis of the evolving therapeutic landscape for Propionic Acidemia (PA), a rare autosomal recessive metabolic…
Non-Cystic Fibrosis Bronchiectasis Pipeline Insight 2025: FDA Approves BRINSUPRI …
In August 2025, the FDA approved Insmed's BRINSUPRI, the first oral therapy for non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 years and older, marking…
Hypovolemia Pipeline Insight 2025: Next-Gen Volume Expanders, Oxygen Therapeutic …
DelveInsight's "Hypovolemia - Pipeline Insight, 2025" provides a comprehensive overview of the therapeutic innovations aimed at managing this life-threatening condition characterized by rapid loss of…
Abdominal Aortic Aneurysm (AAA) Repair Devices Market to Register a CAGR of 5.70 …
The global abdominal aortic aneurysm (AAA) repair devices market is poised for steady growth through 2032, supported by the rising prevalence of aneurysms among the…
Adult-Onset Still Disease Pipeline Insight 2025: IL-1/IL-6 Blockade, JAK Inhibit …
DelveInsight's "Adult-Onset Still Disease - Pipeline Insight, 2025" provides a detailed overview of the evolving therapeutic landscape for this rare systemic autoinflammatory disorder. Traditionally reliant…
Laparoscopy Devices Market to Witness Robust Growth by 2032, Driven by Rising Mi …
The laparoscopy devices market is expected to grow steadily through 2032, driven by the increasing adoption of minimally invasive surgical procedures across gastrointestinal, gynecological, and…
